Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Development of New Biokinetic-Dosimetric Models for the Simulation of Iodine Blockade in the Case of Radioiodine Exposure in Man.

Rump A, Eder S, Lamkowski A, Kinoshita M, Yamamoto T, Abend M, Shinomiya N, Port M.

Drug Res (Stuttg). 2019 Aug 7. doi: 10.1055/a-0960-5590. [Epub ahead of print]

2.

Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.

Kawamura Y, Nakaoka H, Nakayama A, Okada Y, Yamamoto K, Higashino T, Sakiyama M, Shimizu T, Ooyama H, Ooyama K, Nagase M, Hidaka Y, Shirahama Y, Hosomichi K, Nishida Y, Shimoshikiryo I, Hishida A, Katsuura-Kamano S, Shimizu S, Kawaguchi M, Uemura H, Ibusuki R, Hara M, Naito M, Takao M, Nakajima M, Iwasawa S, Nakashima H, Ohnaka K, Nakamura T, Stiburkova B, Merriman TR, Nakatochi M, Ichihara S, Yokota M, Takada T, Saitoh T, Kamatani Y, Takahashi A, Arisawa K, Takezaki T, Tanaka K, Wakai K, Kubo M, Hosoya T, Ichida K, Inoue I, Shinomiya N, Matsuo H.

Ann Rheum Dis. 2019 Oct;78(10):1430-1437. doi: 10.1136/annrheumdis-2019-215521. Epub 2019 Jul 8.

3.

Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.

Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.

Commun Biol. 2019 Apr 8;2:115. doi: 10.1038/s42003-019-0339-0. eCollection 2019.

4.

Clinical practice guideline for renal hypouricemia (1st edition).

Nakayama A, Matsuo H, Ohtahara A, Ogino K, Hakoda M, Hamada T, Hosoyamada M, Yamaguchi S, Hisatome I, Ichida K, Shinomiya N.

Hum Cell. 2019 Apr;32(2):83-87. doi: 10.1007/s13577-019-00239-3. Epub 2019 Feb 19. Review.

5.

Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression.

Takada T, Yamamoto T, Matsuo H, Tan JK, Ooyama K, Sakiyama M, Miyata H, Yamanashi Y, Toyoda Y, Higashino T, Nakayama A, Nakashima A, Shinomiya N, Ichida K, Ooyama H, Fujimori S, Suzuki H.

Sci Rep. 2018 Jul 24;8(1):11147. doi: 10.1038/s41598-018-29208-w.

6.

Common variant of BCAS3 is associated with gout risk in Japanese population: the first replication study after gout GWAS in Han Chinese.

Sakiyama M, Matsuo H, Nakaoka H, Kawamura Y, Kawaguchi M, Higashino T, Nakayama A, Akashi A, Ueyama J, Kondo T, Wakai K, Sakurai Y, Yamamoto K, Ooyama H, Shinomiya N.

BMC Med Genet. 2018 Jun 7;19(1):96. doi: 10.1186/s12881-018-0583-z.

7.

Multiple common and rare variants of ABCG2 cause gout.

Higashino T, Takada T, Nakaoka H, Toyoda Y, Stiburkova B, Miyata H, Ikebuchi Y, Nakashima H, Shimizu S, Kawaguchi M, Sakiyama M, Nakayama A, Akashi A, Tanahashi Y, Kawamura Y, Nakamura T, Wakai K, Okada R, Yamamoto K, Hosomichi K, Hosoya T, Ichida K, Ooyama H, Suzuki H, Inoue I, Merriman TR, Shinomiya N, Matsuo H.

RMD Open. 2017 Aug 29;3(2):e000464. doi: 10.1136/rmdopen-2017-000464. eCollection 2017.

8.

A common variant of MAF/c-MAF, transcriptional factor gene in the kidney, is associated with gout susceptibility.

Higashino T, Matsuo H, Okada Y, Nakashima H, Shimizu S, Sakiyama M, Tadokoro S, Nakayama A, Kawaguchi M, Komatsu M, Hishida A, Nakatochi M, Ooyama H, Imaki J, Shinomiya N.

Hum Cell. 2018 Jan;31(1):10-13. doi: 10.1007/s13577-017-0186-6. Epub 2017 Oct 28.

PMID:
29080939
9.

Correlation between c-Met and ALDH1 contributes to the survival and tumor-sphere formation of ALDH1 positive breast cancer stem cells and predicts poor clinical outcome in breast cancer.

Nozaki Y, Tamori S, Inada M, Katayama R, Nakane H, Minamishima O, Onodera Y, Abe M, Shiina S, Tamura K, Kodama D, Sato K, Hara Y, Abe R, Takasawa R, Yoshimori A, Shinomiya N, Tanuma SI, Akimoto K.

Genes Cancer. 2017 Jul;8(7-8):628-639. doi: 10.18632/genesandcancer.148.

10.

In vivo Lipopolysaccharide Tolerance Recruits CD11b+ Macrophages to the Liver with Enhanced Bactericidal Activity and Low Tumor Necrosis Factor-Releasing Capability, Resulting in Drastic Resistance to Lethal Septicemia.

Kinoshita M, Miyazaki H, Nakashima H, Nakashima M, Nishikawa M, Ishikiriyama T, Kato S, Iwaya K, Hiroi S, Shinomiya N, Seki S.

J Innate Immun. 2017;9(5):493-510. doi: 10.1159/000475931. Epub 2017 Jul 5.

11.

Independent effects of ADH1B and ALDH2 common dysfunctional variants on gout risk.

Sakiyama M, Matsuo H, Akashi A, Shimizu S, Higashino T, Kawaguchi M, Nakayama A, Naito M, Kawai S, Nakashima H, Sakurai Y, Ichida K, Shimizu T, Ooyama H, Shinomiya N.

Sci Rep. 2017 May 31;7(1):2500. doi: 10.1038/s41598-017-02528-z.

12.

MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection.

Sakamoto N, Tsujimoto H, Takahata R, Cao B, Zhao P, Ito N, Shimazaki H, Ichikura T, Hase K, Vande Woude GF, Shinomiya N.

Cancer Sci. 2017 Mar;108(3):322-330. doi: 10.1111/cas.13146.

13.

Expression of a human NPT1/SLC17A1 missense variant which increases urate export.

Sakiyama M, Matsuo H, Nagamori S, Ling W, Kawamura Y, Nakayama A, Higashino T, Chiba T, Ichida K, Kanai Y, Shinomiya N.

Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):536-542.

PMID:
27906618
14.

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.

Nakayama A, Nakaoka H, Yamamoto K, Sakiyama M, Shaukat A, Toyoda Y, Okada Y, Kamatani Y, Nakamura T, Takada T, Inoue K, Yasujima T, Yuasa H, Shirahama Y, Nakashima H, Shimizu S, Higashino T, Kawamura Y, Ogata H, Kawaguchi M, Ohkawa Y, Danjoh I, Tokumasu A, Ooyama K, Ito T, Kondo T, Wakai K, Stiburkova B, Pavelka K, Stamp LK, Dalbeth N; Eurogout Consortium, Sakurai Y, Suzuki H, Hosoyamada M, Fujimori S, Yokoo T, Hosoya T, Inoue I, Takahashi A, Kubo M, Ooyama H, Shimizu T, Ichida K, Shinomiya N, Merriman TR, Matsuo H; Eurogout Consortium.

Ann Rheum Dis. 2017 May;76(5):869-877. doi: 10.1136/annrheumdis-2016-209632. Epub 2016 Nov 29.

15.

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.

Miyamoto M, Takano M, Iwaya K, Shinomiya N, Goto T, Kato M, Suzuki A, Aoyama T, Hitrata J, Nagaoka I, Tsuda H, Furuya K.

Br J Cancer. 2017 Mar 14;116(6):e2. doi: 10.1038/bjc.2016.371. Epub 2016 Nov 10. No abstract available.

16.

Up-Regulation of Antioxidant Proteins in the Plasma Proteome during Saturation Diving: Unique Coincidence under Hypobaric Hypoxia.

Domoto H, Iwaya K, Ikomi F, Matsuo H, Tadano Y, Fujii S, Tachi K, Itoh Y, Sato M, Inoue K, Shinomiya N.

PLoS One. 2016 Oct 14;11(10):e0163804. doi: 10.1371/journal.pone.0163804. eCollection 2016.

17.

Common variant of PDZ domain containing 1 (PDZK1) gene is associated with gout susceptibility: A replication study and meta-analysis in Japanese population.

Higashino T, Matsuo H, Sakiyama M, Nakayama A, Nakamura T, Takada T, Ogata H, Kawamura Y, Kawaguchi M, Naito M, Kawai S, Takada Y, Ooyama H, Suzuki H, Shinomiya N.

Drug Metab Pharmacokinet. 2016 Dec;31(6):464-466. doi: 10.1016/j.dmpk.2016.07.004. Epub 2016 Jul 30.

18.

Meta-analysis confirms an association between gout and a common variant of LRRC16A locus.

Ogata H, Matsuo H, Sakiyama M, Higashino T, Kawaguchi M, Nakayama A, Naito M, Ooyama H, Ichida K, Shinomiya N.

Mod Rheumatol. 2017 May;27(3):553-555. doi: 10.1080/14397595.2016.1218413. Epub 2016 Sep 1. No abstract available.

PMID:
27585540
19.

Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2.

Matsuo H, Tsunoda T, Ooyama K, Sakiyama M, Sogo T, Takada T, Nakashima A, Nakayama A, Kawaguchi M, Higashino T, Wakai K, Ooyama H, Hokari R, Suzuki H, Ichida K, Inui A, Fujimori S, Shinomiya N.

Sci Rep. 2016 Aug 30;6:31003. doi: 10.1038/srep31003.

20.

Fluorescence multispectral imaging-based diagnostic system for atherosclerosis.

Ho CS, Horiuchi T, Taniguchi H, Umetsu A, Hagisawa K, Iwaya K, Nakai K, Azmi A, Zulaziz N, Azhim A, Shinomiya N, Morimoto Y.

Biomed Eng Online. 2016 Aug 20;15(1):98. doi: 10.1186/s12938-016-0220-z.

21.

Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus.

Sakiyama M, Matsuo H, Nakaoka H, Yamamoto K, Nakayama A, Nakamura T, Kawai S, Okada R, Ooyama H, Shimizu T, Shinomiya N.

Sci Rep. 2016 May 16;6:25360. doi: 10.1038/srep25360.

22.

The effects of URAT1/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression.

Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakamura T, Nakayama A, Higashino T, Naito M, Suma S, Hishida A, Satoh T, Sakurai Y, Takada T, Ichida K, Ooyama H, Shimizu T, Shinomiya N.

Sci Rep. 2016 Jan 29;6:20148. doi: 10.1038/srep20148.

23.

NRF2 Is a Key Target for Prevention of Noise-Induced Hearing Loss by Reducing Oxidative Damage of Cochlea.

Honkura Y, Matsuo H, Murakami S, Sakiyama M, Mizutari K, Shiotani A, Yamamoto M, Morita I, Shinomiya N, Kawase T, Katori Y, Motohashi H.

Sci Rep. 2016 Jan 18;6:19329. doi: 10.1038/srep19329.

24.

Carrier frequency of the GJB2 mutations that cause hereditary hearing loss in the Japanese population.

Taniguchi M, Matsuo H, Shimizu S, Nakayama A, Suzuki K, Hamajima N, Shinomiya N, Nishio S, Kosugi S, Usami S, Ito J, Kitajiri S.

J Hum Genet. 2015 Oct;60(10):613-7. doi: 10.1038/jhg.2015.82. Epub 2015 Jul 16.

25.

Photodynamic therapy mediates innate immune responses via fibroblast-macrophage interactions.

Zulaziz N, Azhim A, Himeno N, Tanaka M, Satoh Y, Kinoshita M, Miyazaki H, Saitoh D, Shinomiya N, Morimoto Y.

Hum Cell. 2015 Oct;28(4):159-66. doi: 10.1007/s13577-015-0118-2. Epub 2015 May 22.

PMID:
25997703
26.

ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout.

Matsuo H, Tomiyama H, Satake W, Chiba T, Onoue H, Kawamura Y, Nakayama A, Shimizu S, Sakiyama M, Funayama M, Nishioka K, Shimizu T, Kaida K, Kamakura K, Toda T, Hattori N, Shinomiya N.

Ann Clin Transl Neurol. 2015 Mar;2(3):302-6. doi: 10.1002/acn3.167. Epub 2015 Jan 19.

27.

Abdominal Infection Suppresses the Number and Activity of Intrahepatic Natural Killer Cells and Promotes Tumor Growth in a Murine Liver Metastasis Model.

Matsumoto Y, Tsujimoto H, Ono S, Shinomiya N, Miyazaki H, Hiraki S, Takahata R, Yoshida K, Saitoh D, Yamori T, Yamamoto J, Hase K.

Ann Surg Oncol. 2016 Feb;23 Suppl 2:S257-65. doi: 10.1245/s10434-015-4466-7. Epub 2015 Mar 10.

PMID:
25752891
28.

Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.

Matsuo H, Yamamoto K, Nakaoka H, Nakayama A, Sakiyama M, Chiba T, Takahashi A, Nakamura T, Nakashima H, Takada Y, Danjoh I, Shimizu S, Abe J, Kawamura Y, Terashige S, Ogata H, Tatsukawa S, Yin G, Okada R, Morita E, Naito M, Tokumasu A, Onoue H, Iwaya K, Ito T, Takada T, Inoue K, Kato Y, Nakamura Y, Sakurai Y, Suzuki H, Kanai Y, Hosoya T, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, Shinomiya N.

Ann Rheum Dis. 2016 Apr;75(4):652-9. doi: 10.1136/annrheumdis-2014-206191. Epub 2015 Feb 2.

29.

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.

Miyamoto M, Takano M, Iwaya K, Shinomiya N, Goto T, Kato M, Suzuki A, Aoyama T, Hirata J, Nagaoka I, Tsuda H, Furuya K.

Br J Cancer. 2015 Feb 17;112(4):739-44. doi: 10.1038/bjc.2015.1. Epub 2015 Jan 27. Erratum in: Br J Cancer. 2017 Mar 14;116(6):e2.

30.

Common variant of PDZK1, adaptor protein gene of urate transporters, is not associated with gout.

Takada Y, Matsuo H, Nakayama A, Sakiyama M, Hishida A, Okada R, Sakurai Y, Shimizu T, Ichida K, Shinomiya N.

J Rheumatol. 2014 Nov;41(11):2330-1. doi: 10.3899/jrheum.140573. No abstract available.

PMID:
25362723
31.

Common variant of ALPK1 is not associated with gout: a replication study.

Chiba T, Matsuo H, Sakiyama M, Nakayama A, Shimizu S, Wakai K, Suma S, Nakashima H, Sakurai Y, Shimizu T, Ichida K, Shinomiya N.

Hum Cell. 2015 Jan;28(1):1-4. doi: 10.1007/s13577-014-0103-1. Epub 2014 Oct 19.

32.

NPT1/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout.

Chiba T, Matsuo H, Kawamura Y, Nagamori S, Nishiyama T, Wei L, Nakayama A, Nakamura T, Sakiyama M, Takada T, Taketani Y, Suma S, Naito M, Oda T, Kumagai H, Moriyama Y, Ichida K, Shimizu T, Kanai Y, Shinomiya N.

Arthritis Rheumatol. 2015 Jan;67(1):281-7. doi: 10.1002/art.38884.

33.

ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion.

Takada T, Ichida K, Matsuo H, Nakayama A, Murakami K, Yamanashi Y, Kasuga H, Shinomiya N, Suzuki H.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):275-81. doi: 10.1080/15257770.2013.854902.

PMID:
24940679
34.

ABCG2 dysfunction increases the risk of renal overload hyperuricemia.

Matsuo H, Takada T, Nakayama A, Shimizu T, Sakiyama M, Shimizu S, Chiba T, Nakashima H, Nakamura T, Takada Y, Sakurai Y, Hosoya T, Shinomiya N, Ichida K.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):266-74. doi: 10.1080/15257770.2013.866679.

PMID:
24940678
35.

Identification of a hypouricemia patient with SLC2A9 R380W, a pathogenic mutation for renal hypouricemia type 2.

Chiba T, Matsuo H, Nagamori S, Nakayama A, Kawamura Y, Shimizu S, Sakiyama M, Hosoyamada M, Kawai S, Okada R, Hamajima N, Kanai Y, Shinomiya N.

Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):261-5. doi: 10.1080/15257770.2013.857781.

PMID:
24940677
36.

Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.

Nakayama A, Matsuo H, Nakaoka H, Nakamura T, Nakashima H, Takada Y, Oikawa Y, Takada T, Sakiyama M, Shimizu S, Kawamura Y, Chiba T, Abe J, Wakai K, Kawai S, Okada R, Tamura T, Shichijo Y, Akashi A, Suzuki H, Hosoya T, Sakurai Y, Ichida K, Shinomiya N.

Sci Rep. 2014 Jun 9;4:5227. doi: 10.1038/srep05227.

37.

Common variants of cGKII/PRKG2 are not associated with gout susceptibility.

Sakiyama M, Matsuo H, Chiba T, Nakayama A, Nakamura T, Shimizu S, Morita E, Fukuda N, Nakashima H, Sakurai Y, Ichida K, Shimizu T, Shinomiya N.

J Rheumatol. 2014 Jul;41(7):1395-7. doi: 10.3899/jrheum.131548. Epub 2014 Jun 1.

38.

Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.

Sakiyama M, Matsuo H, Takada Y, Nakamura T, Nakayama A, Takada T, Kitajiri S, Wakai K, Suzuki H, Shinomiya N.

Drug Metab Pharmacokinet. 2014;29(6):490-2. doi: 10.2133/dmpk.DMPK-14-SC-041. Epub 2014 May 27.

39.

X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary.

Miyamoto M, Takano M, Iwaya K, Shinomiya N, Kato M, Aoyama T, Sasaki N, Goto T, Suzuki A, Hitrata J, Furuya K.

Br J Cancer. 2014 Jun 10;110(12):2881-6. doi: 10.1038/bjc.2014.255. Epub 2014 May 22.

40.

Preconditioning methods influence tumor property in an orthotopic bladder urothelial carcinoma rat model.

Miyazaki K, Morimoto Y, Nishiyama N, Satoh H, Tanaka M, Shinomiya N, Ito K.

Mol Clin Oncol. 2014 Jan;2(1):65-70. Epub 2013 Nov 15.

41.

ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload.

Matsuo H, Nakayama A, Sakiyama M, Chiba T, Shimizu S, Kawamura Y, Nakashima H, Nakamura T, Takada Y, Oikawa Y, Takada T, Nakaoka H, Abe J, Inoue H, Wakai K, Kawai S, Guang Y, Nakagawa H, Ito T, Niwa K, Yamamoto K, Sakurai Y, Suzuki H, Hosoya T, Ichida K, Shimizu T, Shinomiya N.

Sci Rep. 2014 Jan 20;4:3755. doi: 10.1038/srep03755.

42.

Remote management for multipoint sensing systems using hetero-core spliced optical fiber sensors.

Goh LS, Anoda Y, Kazuhiro W, Shinomiya N.

Sensors (Basel). 2013 Dec 27;14(1):468-77. doi: 10.3390/s140100468.

43.

Common variants of a urate-associated gene LRP2 are not associated with gout susceptibility.

Nakayama A, Matsuo H, Shimizu T, Takada Y, Nakamura T, Shimizu S, Chiba T, Sakiyama M, Naito M, Morita E, Ichida K, Shinomiya N.

Rheumatol Int. 2014 Apr;34(4):473-6. doi: 10.1007/s00296-013-2924-8. Epub 2013 Dec 24.

44.

Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility.

Sakiyama M, Matsuo H, Shimizu S, Chiba T, Nakayama A, Takada Y, Nakamura T, Takada T, Morita E, Naito M, Wakai K, Inoue H, Tatsukawa S, Sato J, Shimono K, Makino T, Satoh T, Suzuki H, Kanai Y, Hamajima N, Sakurai Y, Ichida K, Shimizu T, Shinomiya N.

Hum Cell. 2014 Jan;27(1):1-4. doi: 10.1007/s13577-013-0081-8. Epub 2013 Dec 7.

45.

Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy.

Xie Q, Su Y, Dykema K, Johnson J, Koeman J, De Giorgi V, Huang A, Schlegel R, Essenburg C, Kang L, Iwaya K, Seki S, Khoo SK, Zhang B, Buonaguro F, Marincola FM, Furge K, Vande Woude GF, Shinomiya N.

Genes Cancer. 2013 Jul;4(7-8):247-60. doi: 10.1177/1947601913501075.

46.

A common variant of organic anion transporter 4 (OAT4/SLC22A11) gene is associated with renal underexcretion type gout.

Sakiyama M, Matsuo H, Shimizu S, Nakashima H, Nakayama A, Chiba T, Naito M, Takada T, Suzuki H, Hamajima N, Ichida K, Shimizu T, Shinomiya N.

Drug Metab Pharmacokinet. 2014;29(2):208-10. Epub 2013 Sep 10.

47.

Common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility.

Nakayama A, Matsuo H, Shimizu T, Ogata H, Takada Y, Nakashima H, Nakamura T, Shimizu S, Chiba T, Sakiyama M, Ushiyama C, Takada T, Inoue K, Kawai S, Hishida A, Wakai K, Hamajima N, Ichida K, Sakurai Y, Kato Y, Shimizu T, Shinomiya N.

Hum Cell. 2013 Dec;26(4):133-6. doi: 10.1007/s13577-013-0073-8. Epub 2013 Aug 29.

48.

Common dysfunctional variants in ABCG2 are a major cause of early-onset gout.

Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T, Kawamura Y, Takada Y, Yamamoto K, Inoue H, Oikawa Y, Naito M, Hishida A, Wakai K, Okada C, Shimizu S, Sakiyama M, Chiba T, Ogata H, Niwa K, Hosoyamada M, Mori A, Hamajima N, Suzuki H, Kanai Y, Sakurai Y, Hosoya T, Shimizu T, Shinomiya N.

Sci Rep. 2013;3:2014. doi: 10.1038/srep02014.

49.

Effect of potato ethanol residue on rat plasma cholesterol levels.

Hashimoto N, Shinomiya N, Saito K, Noda T, Han KH, Fukushima M.

Biosci Biotechnol Biochem. 2013;77(4):850-2. Epub 2013 Apr 7.

50.

Supplemental Content

Loading ...
Support Center